TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 82 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,433 | -0.6% | 38 | 0.0% | 0.00% | – |
Q2 2023 | $1,441 | -47.6% | 38 | -66.4% | 0.00% | – |
Q1 2023 | $2,748 | -61.1% | 113 | -53.5% | 0.00% | -100.0% |
Q4 2022 | $7,057 | +41.1% | 243 | +34.3% | 0.00% | 0.0% |
Q3 2022 | $5,000 | +150.0% | 181 | +182.8% | 0.00% | – |
Q2 2022 | $2,000 | 0.0% | 64 | +45.5% | 0.00% | – |
Q1 2022 | $2,000 | -92.0% | 44 | -91.3% | 0.00% | -100.0% |
Q4 2021 | $25,000 | -37.5% | 506 | -19.4% | 0.00% | -60.0% |
Q3 2021 | $40,000 | -14.9% | 628 | -3.1% | 0.01% | -9.1% |
Q2 2021 | $47,000 | 0.0% | 648 | +0.8% | 0.01% | 0.0% |
Q1 2021 | $47,000 | 0.0% | 643 | 0.0% | 0.01% | 0.0% |
Q4 2020 | $47,000 | +571.4% | 643 | +431.4% | 0.01% | +450.0% |
Q3 2020 | $7,000 | -36.4% | 121 | -26.2% | 0.00% | -33.3% |
Q2 2020 | $11,000 | -42.1% | 164 | -46.9% | 0.00% | -57.1% |
Q1 2020 | $19,000 | +850.0% | 309 | +1445.0% | 0.01% | +600.0% |
Q4 2019 | $2,000 | 0.0% | 20 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $2,000 | – | 20 | – | 0.00% | – |
Q4 2018 | $0 | – | 0 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 565,951 | $24,483,000 | 8.44% |
Murchinson Ltd. | 162,703 | $7,039,000 | 1.34% |
Eversept Partners, LP | 220,286 | $9,529,572 | 0.73% |
BRANDES INVESTMENT PARTNERS, LP | 379,322 | $16,410,000 | 0.35% |
Analyst IMS Investment Management Services Ltd. | 17,657 | $764,000 | 0.07% |
Claret Asset Management Corp | 7,279 | $315,000 | 0.06% |
ACADIAN ASSET MANAGEMENT LLC | 326,427 | $14,086,000 | 0.06% |
Renaissance Technologies | 678,300 | $29,343,000 | 0.03% |
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 191,820 | $8,298,000 | 0.03% |
ARK Investment Management | 55,566 | $2,404,000 | 0.01% |